Last $54.12 USD
Change Today -0.43 / -0.79%
Volume 235.1K
ABCO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

advisory board co/the (ABCO) Snapshot

Open
$54.46
Previous Close
$54.55
Day High
$54.93
Day Low
$53.90
52 Week High
03/21/14 - $70.14
52 Week Low
12/10/14 - $37.47
Market Cap
2.3B
Average Volume 10 Days
308.0K
EPS TTM
$0.24
Shares Outstanding
42.2M
EX-Date
--
P/E TM
223.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for ADVISORY BOARD CO/THE (ABCO)

advisory board co/the (ABCO) Related Businessweek News

No Related Businessweek News Found

advisory board co/the (ABCO) Details

The Advisory Board Company provides best practices research and analysis, business intelligence and performance technology software, and consulting and management services to the health care and education industries in the United States and internationally. Its best practices research and insight programs include access to studies, executive education, proprietary databases and online services, executive briefings, and other services. The company’s best practices research and insight memberships serve as the foundation of intellectual property across various programs and are focused on understanding industry dynamics, identifying best-demonstrated management practices, critiquing widely-followed but ineffective practices, and analyzing emerging trends within the health care and education industries. Its performance technologies software tools allow members to increase revenue, reduce cost, and enhance quality by pairing their own operational data with the best practices insights from its research; and consulting and management services provides strategic and operational support to member institutions to achieve key clinical quality and financial performance goals, as well as assist member institutions’ efforts to adopt and implement best practices. The company offers its services through discrete programs to approximately 4,500 organizations, including hospitals, health systems, pharmaceutical and biotechnology companies, health care insurers, medical device companies, colleges, universities, and other health care focused organizations and educational institutions. The Advisory Board Company was founded in 1979 and is headquartered in Washington, District of Columbia.

2,800 Employees
Last Reported Date: 01/23/15
Founded in 1979

advisory board co/the (ABCO) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $641.7K
President and Director
Total Annual Compensation: $470.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $325.0K
President of Performance Technologies and Con...
Total Annual Compensation: $425.0K
Executive Vice President
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2014.

advisory board co/the (ABCO) Key Developments

The Advisory Board Company Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Full Year 2015

The Advisory Board Company reported unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported revenue of $150,188,000 against $131,038,000 a year ago. Operating loss was $2,117,000 against operating loss of $7,875,000 a year ago. Loss before provision for income taxes and equity in loss of unconsolidated entity was $3,303,000 against income before provision for income taxes and equity in loss of unconsolidated entity of $8,235,000 a year ago. Net loss attributable to common stockholders was $4,990,000, or $0.14 per basic and diluted share, compared to net income attributable to common stockholders of $3,771,000, or $0.10 per basic and diluted share, for the quarter ended December 31, 2013. Adjusted EBITDA was $22,619,000 against $21,434,000 a year ago. Adjusted net income was $9,498,000, or $0.26 per diluted share, compared to adjusted net income of $9,516,000, or $0.26 per diluted share, for the quarter ended December 31, 2013. For the nine months, the company reported revenue of $436,228,000 against $382,595,000 a year ago. Operating income was $16,217,000 against $30,003,000 a year ago. Income before provision for income taxes and equity in loss of unconsolidated entity was $14,890,000 against $31,977,000 a year ago. Net loss attributable to common stockholders was $1,677,000, or $0.05 per basic and diluted share, compared to net income attributable to common stockholders of $16,465,000, or $0.13 per basic and diluted share, for the quarter ended December 31, 2013. Adjusted EBITDA was $72,044,000 against $66,191,000 a year ago. Adjusted net income was $36,375,000, or $1.00 per diluted share, compared to adjusted net income of $32,257,000, or $0.88 per diluted share, for the quarter ended December 31, 2013. Net cash flows provided by operating activities was $64,899,000 against $73,585,000 a year ago. Purchases of property and equipment was $48,134,000 against $35,692,000 a year ago. For calendar year 2015, the company expects adjusted revenue to be in a range of approximately $780 million to $800 million, adjusted EBITDA to be in a range of approximately $170 million to $180 million, and non-GAAP earnings per diluted share to be in a range of approximately $1.22 to $1.35. For calendar year 2015, the company expects capital expenditures to be in a range of approximately $60 million to $65 million and an effective tax rate in a range of approximately 45% to 47%.

The Advisory Board Company Enters into Credit Agreement with JPMorgan Chase Bank, N.A

The Advisory Board Company entered into a credit agreement, dated as of February 6, 2015, with the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, and the other parties to the agreement. The lenders under the credit agreement on the closing date of February 6, 2015 provided the company with $675 million of senior secured credit facilities for application to the prepayment of all borrowings then outstanding under the company’s prior credit agreement. The credit facilities consist of a five-year senior secured term loan facility in the original principal amount of $575 million and a five-year senior secured revolving credit facility under which up to $100 million principal amount of borrowings and other credit extensions may be outstanding at any time.

The Advisory Board Company to Report Q3, 2015 Results on Feb 11, 2015

The Advisory Board Company announced that they will report Q3, 2015 results at 5:30 PM, US Eastern Standard Time on Feb 11, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABCO:US $54.12 USD -0.43

ABCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allscripts Healthcare Solutions Inc $12.01 USD -0.74
Corporate Executive Board Co/The $78.21 USD -0.67
DeVry Education Group Inc $36.55 USD -0.10
Huron Consulting Group Inc $66.65 USD +0.64
Korn/Ferry International $30.60 USD -0.21
View Industry Companies
 

Industry Analysis

ABCO

Industry Average

Valuation ABCO Industry Range
Price/Earnings 100.0x
Price/Sales 3.4x
Price/Book 6.1x
Price/Cash Flow 51.5x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVISORY BOARD CO/THE, please visit www.advisory.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.